Mirna Therapeutics, Inc. IPO Info
Company Name: Mirna Therapeutics, Inc.
Stock Symbol: MIRN
Exchange: NASDAQ
Status: Priced
IPO Date: 10/1/2015
IPO Price:
7.00 (
-10.71%)
Underwriters
Citigroup, Leerink Partners, Oppenheimer & Co., Cantor Fitzgerald & Co.
Amount of Offering: N/A
Number of Shares Offered: 6.25 Mil
Shares Outstanding After Offering: N/A
Valuation: N/A
Company Description
Mirna Therapeutics is a clinical-stage biopharmaceutical company developing a broad pipeline of microRNA-based oncology therapeutics. microRNAs are naturally occurring, short ribonucleic acid, or RNA, molecules, or oligonucleotides, that play a critical role in regulating key biological pathways.
SEC Filings
News Headlines
